WALTHAM, Mass. and BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (Nasdaq: RGEN), a life...
Full year 2024 reported revenue growth of at least 15% compared to 2023 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and...
Today, 908 Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getingeβs bioreactors with 908 Devicesβ MAVEN for...
Revenue increases 17% compared to prior year, driven by recently acquired handheld products 908 Devices Inc. (Nasdaq: MASS), a pioneer of...
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced it will...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads